U.S. Markets open in 52 mins.

Acorda Therapeutics, Inc. (CDG.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
18.2940.000 (0.000%)
As of 9:08AM CEST. Market open.
Full screen
Previous Close18.294
Open18.294
Bid18.234 x 13500
Ask18.870 x 12900
Day's Range18.294 - 18.294
52 Week Range12.041 - 27.851
Volume10
Avg. Volume22
Market Cap848.25M
BetaN/A
PE Ratio (TTM)-15.70
EPS (TTM)-1.16
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • See what the IHS Markit Score report has to say about Acorda Therapeutics Inc.
    Markit7 days ago

    See what the IHS Markit Score report has to say about Acorda Therapeutics Inc.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

  • Barrons.com9 days ago

    [$$] The Payoff in ADP

    Source: InsiderScore.com Scopia Management issued a letter to Acorda Therapeutics’ board dated Aug. 7, requesting that management and the board of directors “pursue an immediate review of all strategic alternatives, including a sale.” Noting Acorda’s unsuccessful litigation over patents related to its proprietary drug Ampyra, the letter also stated, “If [Acorda] prevailed, it would have been a unique company with a path to $1 billion in revenues and significant stand-alone value. This is similar to Pershing’s investment in Canadian Pacific, in which it ultimately implemented its plan and doubled CP’s profit margins.

  • IHS Markit Score Update: Drop in demand for ETFs holding Acorda Therapeutics Inc is a negative sign for its shares
    Markit11 days ago

    IHS Markit Score Update: Drop in demand for ETFs holding Acorda Therapeutics Inc is a negative sign for its shares

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.